AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Quoin Pharmaceuticals, Ltd. American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00D9PB389
4.02▲ 0.01 (0.25%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
4.01
Day's Range
4.02 – 4.08
52-Week Range
3.25 – 23.50
Volume
2,156
Avg Volume
39.8K
Share Statistics
Shares Outstanding
Employees
6
Exchange
XNAS
Listed
2021-10-28
Share count as of August 12, 2026

Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX)
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Market Cap?
Quoin Pharmaceuticals, Ltd. American Depositary Shares's Market Cap is $282.6M, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Enterprise Value?
Quoin Pharmaceuticals, Ltd. American Depositary Shares's Enterprise Value is $271.8M, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Income (TTM)?
Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Income (TTM) is -$18.7M, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Diluted EPS (TTM)?
Quoin Pharmaceuticals, Ltd. American Depositary Shares's Diluted EPS (TTM) is -0.27, based on as-reported figures from SEC (XBRL) filings.
What is Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Debt?
Quoin Pharmaceuticals, Ltd. American Depositary Shares's Net Debt is -$10.8M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · QNRXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses
General and administrative
Research and development
Total operating expenses
Other (income) and expenses
Unrealized (gain) loss
Realized and accrued interest income
Total other income
Net loss
Basic—
Fully-diluted—